Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer

2005369 citationsJournal Article

Authors

James L. Gulley

Philip M. Arlen · National Institutes of Health

Anne Bastian · National Institutes of Health

Steven Morin · National Institutes of Health

Jennifer L. Marté · National Institutes of Health

Patricia K. Beetham · National Institutes of Health

Kwong‐Yok Tsang · National Institutes of Health

Abstract

This vaccine regimen can be safely given in patients undergoing radiation therapy for localized prostate cancer, with the majority of patients generating a PSA-specific cellular immune response to vaccine.

Topics & Keywords

Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers Hepatitis B Virus Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Cancer Research

Volume 11, Issue 9, pp. 3353-3362

DOI: 10.1158/1078-0432.ccr-04-2062

Field-Weighted Citation Impact: 7.33